Skip to Content

Tesamorelin Injection

Last Updated: October 13, 2014
Status: Resolved

Products Affected - Description

Egrifta, EMD Serono
2 mg vial in 30 count boxes with diluent (NDC 44087-2011-02) - discontinued

 
Egrifta, Theratechnologies
2 mg vial in 30 count boxes with diluent (NDC 62064-0021-30) - discontinued

Reason for the Shortage

  • EMD Serono had Egrifta 2 mg vials on shortage due to manufacturing delays.
  • EMD Serono discontinued Egrifta 1 mg vials in May 2013.
  • Theratechnologies acquired Egrifta from EMD Serono in the spring of 2014.
  • Theratechnologies had Egrifta 2 mg vials on shortage due to manufacturing delays. They have reverted to the 1 mg vials from the 2 mg vials and have begun manufacturing this new presentation.

Available Products

No presentation is available.

 
Egrifta, Theratechnologies
1 mg vial in 30 count boxes with diluent (NDC 62064-0011-60)

Estimated Resupply Dates

Theratechnologies has Egrifta available through specialty pharmacies. Patients must enroll in the Egrifta Assist Program (844-347-4382).

Related Shortages

Updated

October 13, 2014; September 16, 2014; September 4, 2014; June 23, 2014; April 15, 2014; March 17, 2014; February 5, 2014; January 6, 2014; December 3, 2013; October 30, 2013, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide